Evidence mapPaperPMID 40061584Full record

ArticleComplex psychiatry

Clinical, Genomic, and Neurophysiological Correlates of Lifetime Suicide Attempts among Individuals with an Alcohol Use Disorder.

Peter B Barr, Zoe Neale, Chris Chatzinakos, Jessica Schulman, Niamh Mullins, Jian Zhang, David B Chorlian, Chella Kamarajan, Sivan Kinreich, Ashwini K Pandey and 20 more

Abstract read
In one paragraph

Article in Complex psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Peter B BarrDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Zoe NealeDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Chris ChatzinakosDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Jessica SchulmanMultiple Myeloma Research Foundation, Norwalk, CT, USA.
Niamh MullinsDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Jian ZhangDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
David B ChorlianDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Chella KamarajanDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Sivan KinreichDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Ashwini K PandeyDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Gayathri PandeyDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Stacey Saenz de ViteriSchool of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Laura AcionDepartment of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Lance BauerDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Kathleen K BucholzDepartment of Psychiatry, School of Medicine, Washington University in St. Louis, St Louis, MO, USA.
Grace ChanDepartment of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Danielle M DickDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
Howard J EdenbergDepartment of Medical and Molecular Genetics, School of Medicine, Indiana University, Indianapolis, IN, USA.
Tatiana ForoudDepartment of Medical and Molecular Genetics, School of Medicine, Indiana University, Indianapolis, IN, USA.
Alison GoateDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Victor HesselbrockDepartment of Psychiatry, School of Medicine, University of Connecticut, Farmington, CT, USA.
Emma C JohnsonDepartment of Psychiatry, School of Medicine, Washington University in St. Louis, St Louis, MO, USA.
John R KramerDepartment of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Dongbing LaiDepartment of Medical and Molecular Genetics, School of Medicine, Indiana University, Indianapolis, IN, USA.
Martin H PlaweckiDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.
Jessica SalvatoreDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
Leah WetherillDepartment of Medical and Molecular Genetics, School of Medicine, Indiana University, Indianapolis, IN, USA.
Arpana AgrawalDepartment of Psychiatry, School of Medicine, Washington University in St. Louis, St Louis, MO, USA.
Bernice PorjeszDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Jacquelyn L MeyersDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.

Funding

Lifespan ProjectU10AA008401 · SUNY DOWNSTATE MEDICAL CENTER · 1989 to 2025
$18.1M
NIAAA NIH HHS U10 AA008401
6 · The paper itself

Abstract

Introduction: Research has identified multiple risk factors associated with suicide attempt (SA) among individuals with psychiatric illness. However, there is limited research among those with an alcohol use disorder (AUD), despite their disproportionately higher rates of SA. Methods: We examined lifetime SA in 4,068 individuals with an AUD from the Collaborative Study on the Genetics of Alcoholism (23% lifetime SA; 53% female; mean age: 38). We explored risk for lifetime SA across other clinical conditions ascertained from a clinical interview, polygenic scores for comorbid psychiatric problems, and neurocognitive functioning. Results: Participants with an AUD who attempted suicide had greater rates of trauma exposure, major depressive disorder, post-traumatic stress disorder, other substance use disorders (SUDs), and suicidal ideation. Polygenic scores for SA, depression, and PTSD were associated with increased odds of reporting an SA (ORs = 1.22-1.44). Participants who reported an SA also had decreased right hemispheric frontal-parietal theta and decreased interhemispheric temporal-parietal alpha electroencephalogram resting-state coherences relative to those who did not, but differences were small. Conclusions: Overall, individuals with an AUD who report lifetime SA experience greater levels of trauma, have more severe comorbidities, and carry increased polygenic risk for other psychiatric problems. Our results demonstrate the need to further investigate SAs in the presence of SUDs.

Indexed as

Alcohol use disorderPolygenic scoreSuicide

Identifiers

PMID40061584
PMCPMC11888779

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.